Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases

Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases

US Patent 9717772 · Granted Aug 1, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treating undesired implanted tissue filler2025
Composition comprising botulinum toxin2024
Systems and methods for combined cosmetic treatment of cellulite with ultrasound2024
Treatment of neurodegenerative eye disease using pridopidine2023
Methods for the treatment of glaucoma and age-related macular degeneration by a 2021
Methods for the treatment of glaucoma and age-related macular degeneratiion by a2020
Glycine B antagonist2012
Glycine B antagonist2012
Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modula2011
Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modula2011
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modula2011
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modula2011